Moreover, studies suggest a role for TLR-2 in MS pathogenesis, since T cells lacking TLR-2 can only induce mild clinical EAE associated with lower CD4+ and CD11b+ cell infiltration of the CNS [50], [51]. Here, CD4 is linked to myeloid sarcoma.